Therefore, elucidating the mechanisms by which macrophage glycolytic reprogramming affects NLRP3 inflammasome activation is critical for advancing the study and treatment of ALI/ARDS. The gene discussed is NLRP3; the disease is acute respiratory distress syndrome.